Pharma Safety: Differentiating Spurious Drugs and Not Standard Quality Drugs
Understanding the Differences: Spurious Drugs vs Not Standard Quality Drugs
Recent guidelines from the Central Drugs Standards Control Organisation (CDSCO) have identified a troubling number of drugs labeled as Not Standard Quality (NSQ). This announcement has triggered significant concern throughout the pharmaceutical industry, particularly among trusted names like Sun Pharma and Alchem. NSQ indicates drugs that fail to meet the quality standards defined by regulatory bodies, potentially due to labeling errors or variations in active ingredient concentrations.
What Constitutes Spurious Drugs?
Conversely, the term spurious drugs refers to counterfeit medications that may contain dangerous or ineffective ingredients. These drugs are often poorly manufactured and may not contain the active components as promised, leading to significant health risks.
Implications of NSQ and Spurious Drugs
- The CDSCO emphasizes the need for clear distinctions between NSQ and spurious drugs to protect the reputation of legitimate manufacturers.
- Manufacturers of spurious drugs face severe penalties, including the potential for criminal charges and incarceration.
- Consumers must be educated to distinguish between NSQ and spurious drugs effectively.
Industry experts recommend implementing technological solutions, such as QR codes, to verify drug authenticity, thereby empowering consumers and ensuring safety.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.